AGP Executive Report
Last update: 2 hours agoMS Classification Debate: A new JAMA Neurology discussion questions whether today’s multiple sclerosis labels still match how the disease behaves in real life, especially as treatments curb relapses but many patients keep progressing. Drug Pricing Power Play: An access-to-medicines advocate argues drug pricing is less about “cost” and more about who holds leverage over policy and patents. Hantavirus Response: Health authorities are moving to protect against Andes hantavirus after a cruise-related scare, with liability coverage for a potential countermeasure (favipiravir) under a federal emergency framework. Manitoba Violence: RCMP are searching for a suspect after two men were shot on an ATV on a northern Manitoba First Nation; one victim faces life-threatening injuries. MAiD Scrutiny: Ontario’s medical regulator reviewed a case where a doctor assessed and later administered MAiD after meeting a patient at a Tim Hortons. Workforce Signals: A jobs report says healthcare and trades are hiring while some roles are shrinking, pointing to structural change rather than a simple jobs collapse.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
